The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPKD.L Regulatory News (BPKD)

  • There is currently no data for BPKD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Determination by UniCredit the selling price

13 Jul 2016 11:48

RNS Number : 0832E
Bank Pekao S.A.
13 July 2016
 

NOT FOR RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA.

 

13.07.2016 - Report 16/2016: Information on the determination by UniCredit S.p.A. the selling price and number of shares in the sale of shares consisting approximately 10.0 % of the share capital of Bank Pekao S.A. in the way of accelerated book building

The Management Board of Bank Pekao S.A. (the "Bank") hereby informs that became aware on publication by UniCredit S.p.A. ("UniCredit") an announcement on the determination by UniCredit the selling price and number of shares sold in the sale of shares consisting approximately 10.0 % of the share capital of the Bank in the way of accelerated bookbuilding with the following information:

"Further to the press release published today, UniCredit S.p.A. ("UniCredit") announces that it has sold 26.2 million existing ordinary shares in Bank Pekao S.A. ("Pekao" or the "Company") to institutional investors, corresponding to approximately 10.0% of the Company's issued share capital, at a price of 126 PLN per ordinary share in an accelerated placement (the "Placement").

Gross proceeds raised by UniCredit from the Placement amounted to approximately PLN 3.3 billion (equal to c. € 749 million*). The price represents a discount of approximately 6% to the last pre-announcement closing price of Pekao and is estimated to translate to an increase of approximately 12 basis points in the UniCredit Group CET1 ratio.

After the completion of the Placement, UniCredit continues to hold a controlling shareholding in Pekao, corresponding to 40.1% of the Company's share capital. In the context of the Placement, UniCredit has agreed to a 90 days lock-up period with respect to its remaining controlling shareholding in Pekao, subject to customary carve-outs.

This transaction, following closely after the successful placing of 10% of FinecoBank's ordinary share capital concluded this morning, is another firm indication that UniCredit will act decisively and swiftly to seize value creative opportunities in line with its renewed focus on strictly disciplined capital management and pro-active capital optimisation actions. In the meantime, UniCredit confirms its key focus on delivering its unique Western, Eastern and Central European network to its extensive client base.

Morgan Stanley & Co. International plc, Citigroup, UBS Limited and UniCredit Corporate & Investment Banking acted as Joint Bookrunners for the Placement.

* Assuming EUR/PLN exchange rate equal to 4.4171 (ECB foreign exchange reference rate as of 12 July 2016)."

Legal basis:

Article 17 sec. 1 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC

 

Legal disclaimer

The communication constitutes fulfillment of disclosure obligations to which the Bank is subject a public company with shares listed on a regulated market in Poland and is not an offer for sale of securities in the United States or any other jurisdiction. Securities may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "Securities Act"). UniCredit does not intend to register any portion of the Placement in the United States, and does not intend to conduct a public offering of securities in the United States.

This communication in the United States is intended only for QIBs and by accepting delivery of this communication in the United States you confirm that you are a QIB. The securities referred to herein may only be sold pursuant to Regulation S of the Securities Act and in the US, pursuant to an exemption from the Securities Act, strictly only to a limited number of QIBs (as defined in Rule 144A under the Securities Act) and in certain other countries only to authorised professional institutional investors. The securities are "restricted securities" as defined in Rule 144A under the Securities Act and any allocation will only be made on the basis the purchaser executes an investor representation letter.

Distribution in Canada to Accredited Investors in Ontario and Quebec, might only be available to accounts which are also permitted clients.

The material set forth herein is for information purposes only and is not an offer to sell, or the solicitation of an offer to buy, any securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful and, in particular, is not for release, publication or distribution in or into the United States, Australia, Canada or Japan.

The publication of this information does not constitute the making available of information to

promote the purchase or acquisition of securities or an inducement of their purchase or acquisition within the meaning of Article 53 section 1 of Polish Act of 29 July 2005 on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organised Trading, and Public Companies, as amended (the "Act on Public Offering"), and does not constitute a promotional campaign within the meaning of Article 53 of the Act on Public Offering.

This communication and any subsequent offer of securities may be restricted by law in certain jurisdictions and persons receiving this communication or any subsequent offer should inform themselves about and observe any such restriction and must not under any circumstances forward this communication to any other person. Failure to comply with such restrictions may violate securities laws of any such jurisdiction.

This communication is only addressed to and directed at persons in Member States of the European Economic Area who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive. In addition, in the United Kingdom, this communication is being distributed to, and is directed only at, qualified investors who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Financial Promotion Order"), (ii) persons falling within any of the categories of persons described in Article 49 of the Financial Promotion Order and (iii) any other persons to whom it may otherwise lawfully be made (all such persons together being referred to as "relevant persons").

Any investment or investment activity to which these materials relate are available only to relevant persons in the United Kingdom and qualified investors in any member state of the European Economic Area other than the United Kingdom, and will only be engaged with such persons.

Any investment decision to buy shares must be made solely on the basis of publicly available information. Such information is not the responsibility of Morgan Stanley & Co. International plc, Citi, UBS Limited and UniCredit Bank AG and has not been independently verified by Morgan Stanley & Co. International plc, Citi, UBS Limited and UniCredit Bank AG or UniCredit.

Morgan Stanley & Co. International plc, Citi, UBS Limited and UniCredit Bank AG are acting for UniCredit and no one else in connection with the offering and will not be responsible to anyone other than UniCredit for providing advice or protections afforded to clients in relation to any transaction or any matters referred to this communication.

Each of Morgan Stanley & Co. International plc, Citi, UBS Limited and UniCredit Bank AG may participate in the offering on a proprietary basis.

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADMGMNGFVGVZM
Date   Source Headline
20th Jan 20168:42 amRNSConfirmed Bank's ratings by Standard & Poor's
22nd Dec 20155:42 pmRNSDates of financial statements release in 2016
26th Nov 20155:35 pmRNSNotification from the Bank Guarantee Fund
25th Nov 20157:00 amRNSInformation from the Bank Guarantee Fund
24th Nov 20159:40 amRNSBank's ratings affirmed by Fitch Ratings
10th Nov 20152:53 pmRNS3rd Quarter Results
24th Sep 20154:24 pmRNSBank's shareholder filing an appeal
22nd Sep 20152:54 pmRNSBank's shareholder filing an appeal
4th Aug 20157:16 amRNSHalf Yearly Report
2nd Jul 20155:33 pmRNSChange of Financial Statement Release Date
1st Jul 20155:30 pmRNSMaintaining Bank's ratings, change Outlook
9th Jun 20154:46 pmRNSNew a Member and Chairman of Audit Committee
29th May 20154:14 pmRNSDismissal the shareholder's appeal
27th May 20155:17 pmRNSAmendments to the Bank's Statute
13th May 20156:23 pmRNSDismissal of the claim to overrule the resolution
12th May 20157:02 amRNS1st Quarter Results
6th May 20155:13 pmRNSShareholders with at least 5% votes on OGM
5th May 20152:34 pmRNSAdopted amendments to the Bank's Statute
5th May 20152:31 pmRNSResolutions of the Ordinary General Meeting
1st May 20157:00 amRNSDividend Declaration
1st May 20157:00 amRNSDismissal the shareholder's appeal
1st May 20157:00 amRNSAppointment of member of the Management Board
1st May 20157:00 amRNSOpening the winding-up of the subsidiary
1st May 20157:00 amRNSAppointment of members of the Supervisory Board
29th Apr 20157:00 amRNSCandidates to the Supervisory Board of Bank
29th Apr 20157:00 amRNSResignation of two Members of Supervisory Board
31st Mar 20154:03 pmRNSNotice of AGM
31st Mar 20153:51 pmRNSIntended amendments to the Bank's Statute
12th Mar 20155:37 pmRNSNon application of Rule no I.12, IV.10 subpoint2
11th Feb 20154:34 pmRNSDismissal of the shareholder's complaint
11th Feb 20159:43 amRNS2014 Annual Financial Report
11th Feb 20159:37 amRNS2014 Consolidated Annual Financial Report
11th Feb 20159:10 amRNSProposed dividend in the amount of PLN10 per share
6th Feb 20154:45 pmRNSdeletion of Bank's subsidiary - Pekao Telecentrum
22nd Dec 20144:44 pmRNSHigh Bank's ratings affirmed by S&P
18th Dec 20145:35 pmRNSBank's shareholder filing an appeal
18th Dec 20145:34 pmRNSBank's shareholder filing an appeal
5th Dec 20146:08 pmRNSAcquisition of SKOK named Nicolaus Copernicus
1st Dec 20145:19 pmRNSDates of financial statements release in year 2015
27th Nov 20145:40 pmRNSBank's ratings affirmed by Fitch Ratings
26th Nov 20145:29 pmRNSDismissal of the claim to overrule the resolution
10th Nov 20147:00 amRNS3rd Quarter Results
3rd Nov 20145:13 pmRNSDismissal of the claim to overrule the resolutions
27th Oct 20147:00 amRNSAsset Quality Review (AQR) and Stress Tests - KNF
22nd Oct 20142:40 pmRNSInformation on sale of financial instruments
22nd Sep 201411:07 amRNSBank's shareholder filling complaint
5th Aug 20142:24 pmRNSHalf Yearly Report
5th Aug 20142:15 pmRNSRejection of the shareholder cassation appeal
15th Jul 20144:35 pmRNSDismissal of plaintiff
7th Jul 20147:00 amRNSBank's shareholder filing an appeal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.